Category : Healthcare and Pharmaceuticals | Published at : January-2021 | Delivery Format : PDF | Status: Published | Pages : 190
The market for tissue processing systems is expected to grow at a CAGR of around 5.0% from 2020 to 2027 and expected to reach the market value of around US$ 447.6 Mn by 2027.
Tissue processing refers to the process of preparing the tissue by embedding it in a solid medium that is firm enough to support it and can give enough rigidity to enable cutting of thin sections and yet soft enough to enable the knife to cut the sections with little damage to the knife or tissue. Additionally, the stages of tissue processing include collection, labeling & fixation of specimen, dehydration, clearing, impregnation, embedding, and trimming & sectioning among others. Moreover, the tissue processing systems are designed to help in a simultaneous increase in quality and throughput of specimen processing with built-in quality, reliability, and tissue protection. The tissue processing systems are based on technologies including microwave tissue processors and vacuum tissue processors.
Market Dynamics
The increasing healthcare expenditure along with the rising aging population, increasing cases of lifestyle diseases, advancement in technology and increasing government initiatives to offer affordable advanced healthcare solutions are some of the prominent factors driving the market growth. The rapid changes in healthcare reforms and disproportionately growing aging population are bolstering the regional market value. The growing geriatric population results in an increasing patient population which will gradually increase the need for screening and diagnosis for a large number of chronic diseases. Furthermore, the increasing investment in the healthcare sector for developing and offering advanced solutions in the market is anticipated to create potential opportunities over the forecast period from 2020 to 2027.
On the other side, strict rules & regulations associated with tissue processing system are projected to hinder the growth over the forecast period from 2020 to 2027.
Segment Instance of Global Tissue Processing Systems Market
Small Volume Processors segment is leading the market with maximum revenue share in the global market
By volume, the small volume processors segment has registered maximum revenue share in the global tissue processing market. These are suitable for small laboratory sizes as well as also save space is the factors supporting its demand and growth in the market. For instance, the Leica TP1020 semi-enclosed rotary processor is designed for reliability and economy. It can optimize laboratory space with the small footprint of the HistoCore PEARL tissue processor. It’s a semi-enclosed benchtop tissue processor with small volumes (≤200 blocks/day).
Asia Pacific is projected to exhibit fastest growth over the forecast period from 2020 to 2027
The Asia Pacific region along with its major economies including Japan, China, and India is experiencing major growth in the tissue processing systems market. The region is projected to exhibit the fastest growth with maximum CAGR (%) over the forecast timeframe from 2020 to 2027. The developing healthcare infrastructure along with the increasing initiatives by the government and healthcare institutions for providing advanced solutions to the patients is further bolstering the regional market value. The rapidly growing geriatric population of the developing economies of the region is further bolstering the regional market value.
Key Market Players
The players profiled in the report include Agilent Technologies, Inc., Avantor, Inc., BioGenex, F. Hoffmann-La Roche AG, Leica Biosystems Nussloch GmbH (Danaher), Milestone Medical, MiltenyiBiotec, Sakura Finetek USA, Inc., Siemens AG, Thermo Fisher Scientific Inc., and others.
Market Segmentation
Market By Product
Tissue Transfer Processors
Fluid Transfer Processors
Market By Volume
Small Volume Processors
Medium Volume Processors
Large Volume Processors
Market By Modality
Stand-Alone Tissue Processing Unit
Bench-Top Tissue Processing Unit
Market By End User
Hospitals
Pharmaceutical Companies
Research Laboratories
Others
Market By Geography
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
The market for tissue processing systems is expected to reach a market value of around US$ 447.6 Mn by 2027.
The tissue processing systems market is expected to grow at a CAGR of around 5.0% from 2020 to 2027.
The small volume processors is the leading segment by volume in the tissue processing systems market
The increasing healthcare expenditure, rising ageing population, increasing cases of lifestyle diseases, advancement in the technology and increasing government initiatives to offer affordable advanced healthcare solutions, rapid changes in healthcare reforms and disproportionately growing aging population, and increasing patient population which will gradually increase the need of screening and diagnosis for a large number of chronic diseases are some of the factors driving the market growth.
Agilent Technologies, Inc., Avantor, Inc., BioGenex, F. Hoffmann-La Roche AG, Leica Biosystems Nussloch GmbH (Danaher), Milestone Medical, MiltenyiBiotec, Sakura Finetek USA, Inc., Siemens AG, Thermo Fisher Scientific Inc., and others are the prominent players in the tissue processing systems market.
Asia Pacific is projected to hold the highest market share in the tissue processing systems market in 2027.
Asia Pacific is expected to be the fastest growing market over the forecast period
